UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000002287
Receipt No. R000002737
Scientific Title A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
Date of disclosure of the study information 2009/08/03
Last modified on 2016/08/08 14:46:15

No. Disposal Last modified on Item of update
1 Insert 2009/08/03 15:14:30
2 Update 2012/02/06 15:05:56 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2013/08/12 13:10:59 Organization
4 Update 2013/08/12 13:18:42 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2013/08/15 10:43:50 Last follow-up date
6 Update 2016/08/08 14:46:15 Recruitment status

Contact us.